Dr. Lal PathLabs Ltd
NSE:LALPATHLAB

Watchlist Manager
Dr. Lal PathLabs Ltd Logo
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
Watchlist
Price: 3 053.65 INR 0.91% Market Closed
Market Cap: 254.4B INR
Have any thoughts about
Dr. Lal PathLabs Ltd?
Write Note

Intrinsic Value

The intrinsic value of one LALPATHLAB stock under the Base Case scenario is 1 872.37 INR. Compared to the current market price of 3 053.65 INR, Dr. Lal PathLabs Ltd is Overvalued by 39%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LALPATHLAB Intrinsic Value
1 872.37 INR
Overvaluation 39%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Dr. Lal PathLabs Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for LALPATHLAB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about LALPATHLAB?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Dr. Lal PathLabs Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Dr. Lal PathLabs Ltd

Provide an overview of the primary business activities
of Dr. Lal PathLabs Ltd.

What unique competitive advantages
does Dr. Lal PathLabs Ltd hold over its rivals?

What risks and challenges
does Dr. Lal PathLabs Ltd face in the near future?

Has there been any significant insider trading activity
in Dr. Lal PathLabs Ltd recently?

Summarize the latest earnings call
of Dr. Lal PathLabs Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Dr. Lal PathLabs Ltd.

Provide P/S
for Dr. Lal PathLabs Ltd.

Provide P/E
for Dr. Lal PathLabs Ltd.

Provide P/OCF
for Dr. Lal PathLabs Ltd.

Provide P/FCFE
for Dr. Lal PathLabs Ltd.

Provide P/B
for Dr. Lal PathLabs Ltd.

Provide EV/S
for Dr. Lal PathLabs Ltd.

Provide EV/GP
for Dr. Lal PathLabs Ltd.

Provide EV/EBITDA
for Dr. Lal PathLabs Ltd.

Provide EV/EBIT
for Dr. Lal PathLabs Ltd.

Provide EV/OCF
for Dr. Lal PathLabs Ltd.

Provide EV/FCFF
for Dr. Lal PathLabs Ltd.

Provide EV/IC
for Dr. Lal PathLabs Ltd.

Show me price targets
for Dr. Lal PathLabs Ltd made by professional analysts.

What are the Revenue projections
for Dr. Lal PathLabs Ltd?

How accurate were the past Revenue estimates
for Dr. Lal PathLabs Ltd?

What are the Net Income projections
for Dr. Lal PathLabs Ltd?

How accurate were the past Net Income estimates
for Dr. Lal PathLabs Ltd?

What are the EPS projections
for Dr. Lal PathLabs Ltd?

How accurate were the past EPS estimates
for Dr. Lal PathLabs Ltd?

What are the EBIT projections
for Dr. Lal PathLabs Ltd?

How accurate were the past EBIT estimates
for Dr. Lal PathLabs Ltd?

Compare the revenue forecasts
for Dr. Lal PathLabs Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Dr. Lal PathLabs Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Dr. Lal PathLabs Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Dr. Lal PathLabs Ltd compared to its peers.

Compare the P/E ratios
of Dr. Lal PathLabs Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Dr. Lal PathLabs Ltd with its peers.

Analyze the financial leverage
of Dr. Lal PathLabs Ltd compared to its main competitors.

Show all profitability ratios
for Dr. Lal PathLabs Ltd.

Provide ROE
for Dr. Lal PathLabs Ltd.

Provide ROA
for Dr. Lal PathLabs Ltd.

Provide ROIC
for Dr. Lal PathLabs Ltd.

Provide ROCE
for Dr. Lal PathLabs Ltd.

Provide Gross Margin
for Dr. Lal PathLabs Ltd.

Provide Operating Margin
for Dr. Lal PathLabs Ltd.

Provide Net Margin
for Dr. Lal PathLabs Ltd.

Provide FCF Margin
for Dr. Lal PathLabs Ltd.

Show all solvency ratios
for Dr. Lal PathLabs Ltd.

Provide D/E Ratio
for Dr. Lal PathLabs Ltd.

Provide D/A Ratio
for Dr. Lal PathLabs Ltd.

Provide Interest Coverage Ratio
for Dr. Lal PathLabs Ltd.

Provide Altman Z-Score Ratio
for Dr. Lal PathLabs Ltd.

Provide Quick Ratio
for Dr. Lal PathLabs Ltd.

Provide Current Ratio
for Dr. Lal PathLabs Ltd.

Provide Cash Ratio
for Dr. Lal PathLabs Ltd.

What is the historical Revenue growth
over the last 5 years for Dr. Lal PathLabs Ltd?

What is the historical Net Income growth
over the last 5 years for Dr. Lal PathLabs Ltd?

What is the current Free Cash Flow
of Dr. Lal PathLabs Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Dr. Lal PathLabs Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dr. Lal PathLabs Ltd

Current Assets 13.3B
Cash & Short-Term Investments 11.6B
Receivables 911m
Other Current Assets 738m
Non-Current Assets 12.7B
Long-Term Investments 593m
PP&E 3.3B
Intangibles 8.3B
Other Non-Current Assets 561m
Current Liabilities 4.6B
Accounts Payable 2.1B
Other Current Liabilities 2.5B
Non-Current Liabilities 1.3B
Long-Term Debt 968m
Other Non-Current Liabilities 367m
Efficiency

Earnings Waterfall
Dr. Lal PathLabs Ltd

Revenue
23.5B INR
Cost of Revenue
-4.6B INR
Gross Profit
18.8B INR
Operating Expenses
-13.7B INR
Operating Income
5.2B INR
Other Expenses
-1.1B INR
Net Income
4B INR

Free Cash Flow Analysis
Dr. Lal PathLabs Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q2 FY '25, the company reported revenues of INR 660 crores, a 9.8% increase, with profit after tax rising 18.1% to INR 131 crores. Revenue per patient improved by 5.7% to INR 844, driven by higher sample volumes. The expansion plan includes opening 15 to 20 new labs this financial year, targeting Tier 3 and 4 markets. The company's growth strategy includes increased bundled testing for chronic diseases. With ongoing investments in technology, the EBITDA margin stands at 30.7%, with an expectation to maintain or slightly exceed prior year margins. The second interim dividend announced is INR 6 per share.

What is Earnings Call?
Fundamental Scores

LALPATHLAB Profitability Score
Profitability Due Diligence

Dr. Lal PathLabs Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive 3-Year Average ROE
64/100
Profitability
Score

Dr. Lal PathLabs Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

LALPATHLAB Solvency Score
Solvency Due Diligence

Dr. Lal PathLabs Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
97/100
Solvency
Score

Dr. Lal PathLabs Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LALPATHLAB Price Targets Summary
Dr. Lal PathLabs Ltd

Wall Street analysts forecast LALPATHLAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LALPATHLAB is 3 220.53 INR with a low forecast of 2 424 INR and a high forecast of 3 958.5 INR.

Lowest
Price Target
2 424 INR
21% Downside
Average
Price Target
3 220.53 INR
5% Upside
Highest
Price Target
3 958.5 INR
30% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for LALPATHLAB?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for LALPATHLAB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

LALPATHLAB Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Dr. Lal PathLabs Ltd Logo
Dr. Lal PathLabs Ltd

Country

India

Industry

Health Care

Market Cap

254.4B INR

Dividend Yield

0.98%

Description

Dr. Lal PathLabs Ltd. engages in the business of running laboratories for carrying out pathological investigations. The company is headquartered in Gurgaon, Haryana and currently employs 4,110 full-time employees. The company went IPO on 2015-12-23. The firm is also engaged in running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, and other pathological and radiological investigations. The firm offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder and viral infections. The Company’s subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, Dr. Lal PathLabs Nepal Private Limited, Dr. Lal PathLabs Bangladesh Pvt. Ltd. and Dr. Lal Ventures Private Limited.

Contact

HARYANA
Gurgaon
12th Floor, Tower B, SAS Tower, Sector 38,, Medicity,
+911243016557
www.lalpathlabs.com

IPO

2015-12-23

Employees

4 110

Officers

Executive Chairman
Brigadier Arvind Lal
MD & Director
Dr. Om Prakash Manchanda
Executive Director
Dr. Vandana Lal
Chief Executive Officer
Mr. Shankha Banerjee
Group CFO & CEO of International Business
Mr. Ved Prakash Goel C.A.
Chief Operating Officer
Mr. Jai Prakash Meena
Show More
Chief Information & Digital Officer
Mr. Munender Soperna
Company Secretary & Compliance Officer
Mr. Vinay Gujral
Group Chief Human Resources Officer
Mr. Manoj Kumar Garg
Show Less

See Also

Discover More
What is the Intrinsic Value of one LALPATHLAB stock?

The intrinsic value of one LALPATHLAB stock under the Base Case scenario is 1 872.37 INR.

Is LALPATHLAB stock undervalued or overvalued?

Compared to the current market price of 3 053.65 INR, Dr. Lal PathLabs Ltd is Overvalued by 39%.

Back to Top